Bosutris 400mg Tablet - MediPriceHub

Reference priceKRW ₩135,168.75Original source price: INR 8,343.75. Converted estimates are available by currency selection.

Brand	Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Manufacturer	Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Prescription required	Yes

Description

Bosutris 400mg Tablet contains the active ingredient bosutinib. It belongs to the group of medications called Tyrosine kinase inhibitors. It is indicated to treat adult patients with a type of leukemia known as Philadelphia chromosome-positive (Ph-positive) Chronic Myeloid Leukaemia (CML) who have been newly diagnosed or for whom earlier CML treatments have either failed or have not worked or are not suitable. Philadelphia chromosome-positive chronic myelogenous leukemia is a blood cancer in which the body produces too many of a specific kind of white blood cell called granulocytes.

Benefits

In Blood cancer (Chronic myeloid leukaemia) Blood cancer, also known as leukemia, is a cancer of the white blood cells or WBCs, that decreases the body's ability to fight infection. Bosutris 400 Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.

How to Use

Take this medicine in the dose and duration as advised by your doctor.

Specification

Take this medicine in the dose and duration as advised by your doctor.

Side Effects

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Bosutris Abdominal pain Nausea Vomiting Diarrhea Headache Cough Low blood platelets Anemia (low number of red blood cells) Nasopharyngitis (inflammation of the throat and nasal passages) Respiratory tract infection Decreased white blood cell count (neutrophils) Breathlessness Increased liver enzymes

This information is for reference only. Consult a qualified healthcare professional before using any medicine.